PlexusDx offers compounded semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan, while tirzepatide options range $289/mo month-to-month, or from $249/mo on the 6-month plan to $309 monthly, depending on formulation and dose
Total Peptide: 1 milligram (mg) Conversion: 1 mg = 1000 micrograms (mcg) Total Liquid Volume: 1 milliliter (ml) Syringe Type: We'll use a standard U-100 insulin syringe, which has 100 individual tick marks (units) and holds a total of 1ml
This structure gives patients a general sense of what to expect, but the actual amounts, spacing between increases, and final maintenance level are always determined by the prescribing provider rather than read directly off a generic chart
Always wash your hands and wipe the rubber stopper with a fresh alcohol swab before every draw
It really comes down to what works for you and your lifestyle
Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy
